• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.

作者信息

Birocchi Simone, Cernuschi Giulia, Podda Gian Marco, Costantino Giorgio

机构信息

Medicina Interna 2, Az. Ospedaliera Ospedale L. Sacco, Università degli Studi di Milano, Via G.B. Grassi, 74, 20157, Milan MI, Italy.

出版信息

Intern Emerg Med. 2013 Apr;8(3):245-8. doi: 10.1007/s11739-012-0816-7. Epub 2012 Jul 31.

DOI:10.1007/s11739-012-0816-7
PMID:22847728
Abstract
摘要

相似文献

1
To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.抗凝还是不抗凝？这是个问题：一种基于医学在线数据库的定量方法，用于分享常见临床问题的证据。
Intern Emerg Med. 2013 Apr;8(3):245-8. doi: 10.1007/s11739-012-0816-7. Epub 2012 Jul 31.
2
Good old warfarin for stroke prevention in atrial fibrillation.用于心房颤动中风预防的老牌药物华法林。
Lancet. 2006 Jun 10;367(9526):1877-8. doi: 10.1016/S0140-6736(06)68819-3.
3
Preventing stroke in patients with atrial fibrillation.预防心房颤动患者的中风。
J Fam Pract. 2000 Jan;49(1):8-9.
4
Atrial fibrillation, is warfarin the only option for stroke prevention?
J Pak Med Assoc. 2011 Mar;61(3):301-2.
5
[The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].[口服抗凝药在心房颤动患者预防卒中中的重要性]
Fortschr Neurol Psychiatr. 2008 Jul;76(7):383-4. doi: 10.1055/s-2008-1038167.
6
Prevention of stroke in patients with atrial fibrillation.心房颤动患者的卒中预防
Med Lett Drugs Ther. 2009 Jun 1;51(1313):41.
7
Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.非风湿性心房颤动和心房扑动的抗凝或抗血小板治疗。
Cochrane Database Syst Rev. 2001(1):CD001938. doi: 10.1002/14651858.CD001938.
8
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].[心房颤动的抗栓治疗。新推荐及治疗选择的背景]
Lakartidningen. 2008;105(37):2478-80.
9
Atrial fibrillation and anticoagulation.心房颤动与抗凝治疗
Med Health R I. 2001 Mar;84(3):96-7.
10
Atrial fibrillation, is warfarin the only option for stroke prevention?心房颤动，华法林是预防中风的唯一选择吗？
J Pak Med Assoc. 2011 Apr;61(4):406-7.

引用本文的文献

1
Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage.
Intern Emerg Med. 2017 Jun;12(4):527-529. doi: 10.1007/s11739-016-1568-6. Epub 2016 Nov 4.
2
To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort.对于初治的高龄房颤患者，使用维生素K拮抗剂（VKA）进行治疗与否：VENPAF队列研究结果
Intern Emerg Med. 2015 Oct;10(7):795-804. doi: 10.1007/s11739-015-1236-2. Epub 2015 Apr 21.

本文引用的文献

1
Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules.口服抗凝剂出血风险：临床预测规则的更新系统评价和性能分析。
Ann Hematol. 2011 Oct;90(10):1191-200. doi: 10.1007/s00277-011-1267-3. Epub 2011 Jun 14.
2
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.验证用于预测心房颤动患者中风和血栓栓塞风险分层方案的有效性：全国队列研究。
BMJ. 2011 Jan 31;342:d124. doi: 10.1136/bmj.d124.
3
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
新型房颤抗凝出血风险评分对预测抗凝出血风险的比较验证：HAS-BLED（高血压、肾功能/肝功能异常、卒中、出血史或倾向、INR 易变、高龄、同时使用药物/酒精）评分。
J Am Coll Cardiol. 2011 Jan 11;57(2):173-80. doi: 10.1016/j.jacc.2010.09.024. Epub 2010 Nov 24.
4
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.尽管进行了抗凝治疗，仍识别出有卒中风险的患者：在抗凝治疗的心房颤动队列中比较当代卒中风险分层方案。
Stroke. 2010 Dec;41(12):2731-8. doi: 10.1161/STROKEAHA.110.590257. Epub 2010 Oct 21.
5
Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.CHADS2 评分预测非风湿性心房颤动患者 C 反应蛋白、左心房淤血和预后的价值。
Am J Cardiol. 2010 Aug 15;106(4):535-8. doi: 10.1016/j.amjcard.2010.03.067.
6
Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry.接受抗凝治疗的静脉血栓栓塞症患者的致命性出血：RIETE 注册研究的结果。
J Thromb Haemost. 2010 Jun;8(6):1216-22. doi: 10.1111/j.1538-7836.2010.03852.x. Epub 2010 Mar 12.
7
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.用于预测有或有动脉粥样血栓形成风险的稳定门诊患者严重出血风险的评分。
Eur Heart J. 2010 May;31(10):1257-65. doi: 10.1093/eurheartj/ehq021. Epub 2010 Feb 24.
8
Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome.临床实践中，非瓣膜性心房颤动的口服抗凝治疗：CHADS(2)评分对治疗结果的影响。
Cardiology. 2010;115(3):200-4. doi: 10.1159/000284450. Epub 2010 Feb 17.
9
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke.年龄相关性差异对缺血性脑卒中患者的特征、绩效指标、治疗趋势和结局的影响。
Circulation. 2010 Feb 23;121(7):879-91. doi: 10.1161/CIRCULATIONAHA.109.892497. Epub 2010 Feb 8.
10
The net clinical benefit of warfarin anticoagulation in atrial fibrillation.华法林抗凝治疗心房颤动的净临床获益。
Ann Intern Med. 2009 Sep 1;151(5):297-305. doi: 10.7326/0003-4819-151-5-200909010-00003.